Navigation Links
Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research

ALBANY, New York, September 29, 2014 /PRNewswire/ --

The global implantable drug delivery devices market will notch US$ 21.1 billion by 2018, recording a CAGR of 8.8% from 2012 through 2018, says the report "Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends and Forecast 2012 - 2018" by Transparency Market Research, a U.S.-based market intelligence company.

The market, which stood at US$11.6 billion in 2011, will benefit from an increasing occurrence of cardiovascular diseases, diabetic retinopathy, colorectal cancer, chronic pain conditions, a growing elderly population worldwide, as well as the high prevalence of unwanted pregnancies. These factors are projected to have the highest impact on the implantable drug delivery devices market over the forecast period. Other low-impact, yet equally vital factors that will propel this market include: favorable initiatives by NGOs and governments, a growing demand (and performance of) minimally-invasive surgeries, as well as a rise in the number of registered interventional cardiologists.

Browse and Buy Implantable Drug Delivery Devices Report:

In addition to growth drivers, the market research report also identifies lucrative growth opportunities for the implantable drug delivery devices market. Participants can explore growth avenues such as biodegradable implantable drug delivery devices and technologies and innovative products in the form of Microchips (especially for conditions such as osteoporosis).

Within implantable drug delivery devices, the largest market share was held by cardiovascular applications as of 2011. The cardiovascular applications segment will further expand with the launch of bio-absorbable stents in 2014, and will thus witness accelerated growth until 2018. In CAGR terms, the biodegradable drug delivery implant technology will overtake the non-biodegradable drug delivery implant technology, as the former does not require additional surgical procedures for device removal, and also purges any side effects that may result from such devices being lodged in the body.

By geographical region, the North American market was the largest in 2011. But, the report estimates that by 2018, the share of North America in the implantable drug delivery devices market will slide. The situation in the Asia Pacific will be quite the opposite, as the market in this region will witness accelerated growth on account of rapidly-emerging nations such as China and India.

Make an Inquiry:

The contraceptive drug delivery implants market holds significance as the adoption rate of various contraceptive products is observed to be high. The largest share in this market was held by Merck - a factor attributed to the popularity of its products such as Implanon Nxt, Implanon, and NuvaRing. Bayer HealthCare comes a close second in the market contraceptive drug delivery implants, propelled by its well-liked hormonal product IUD Mirena. Bayer HealthCare also strengthened its market standing with the launch of IUD Skyla in the United States and hormonal Jaydess in the European market in 2013.

Related and Recent Published Reports by Transparency Market Research 

The report segments the global implantable drug delivery devices market on the basis of product types, by application, by technology, and by geography.

By product, the implantable drug delivery devices market is segmented as: Implantable coronary drug eluting stents, implantable contraceptive drug delivery devices, implantable bio-absorbable stents, implantable brachytherapy seeds, implantable intraocular drug delivery devices, implantable Drug Delivery Devices Market by Technology, implantable drug infusion pumps, biodegradable implantable drug delivery device technology, and non-biodegradable implantable drug delivery device technology.

On the basis of applications, the implantable drug delivery devices market is segmented as: Cardiovascular, ophthalmology, contraception/birth control, oncology, and others (diabetes and chronic pain conditions).

The report also studies the market for implantable drug delivery devices by segmenting it into the following geographical regions: Europe, Asia, North America, and Rest of the World.

Browse the full Implantable Drug Delivery Devices Market Press Release:

About Us: 

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Sheela AK

State Tower, 90 State Street,

Suite 700, Albany NY - 12207

USA/Canada Toll Free: 866-552-3453




Follow us on Facebook

Follow us on Twitter

Follow us on Linkedin

SOURCE Transparency Market Research Pvt. Ltd
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
2. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
8. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
9. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
10. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
(Date:5/21/2020)... ... May 21, 2020 , ... In celebration of Nurses ... a unique set of retail offers and recognized a dedicated group of backers—all ... millions of PPE units have arrived to hospitals through commercial, government, and charity ...
(Date:5/16/2020)... ... May 17, 2020 , ... ... a physician, can provide primary care, injury and illness prevention, wellness promotion ... of injuries and medical conditions. Secondary schools and colleges/universities employ a large ...
(Date:5/16/2020)... ... 16, 2020 , ... Oakworks Medical, a leading manufacturer of Ultrasound, C-arm, and ... lay face down for extended periods and possibly prevent them from needing a ventilator. ... and Pain Management professionals. We used our expertise to design a proning cushion that ...
Breaking Medicine Technology:
(Date:5/14/2020)... ... May 14, 2020 , ... ... Nevada Community Foundation’s COVID-19 Emergency Response Fund in an effort to assist with ... , Nevada Community Foundation and Nevada COVID-19 Response, Relief, and Recovery Task Force ...
(Date:5/14/2020)... ALTO, Calif. (PRWEB) , ... May 13, 2020 , ... ... and more flexibility that allows students to earn their degree in less than two ... Zoom webinar for prospective students interested on Wednesday, May 20, 2020 from 4:00pm to ...
(Date:5/14/2020)... RIDING, Va. (PRWEB) , ... May 14, 2020 ... ... firm for life sciences, biotechnology, and diagnostics companies, has announced the placement of ... . Chakravarty assumes leadership of the company less than two months after it ...
(Date:5/11/2020)... SALT LAKE CITY (PRWEB) , ... May 11, ... ... funding led by SpringTide Investments and Rock Creek Capital ... of intuitive, easy-to-implement digital dermatopathology solutions that can speed the diagnostic process while ...
(Date:5/11/2020)... ... May 12, 2020 , ... In direct response to the national need ... ME. This second plant will allow the company to produce an additional 20 to ... called into service by the Defense Production Act, which requires increasing domestic capacity for ...
Breaking Medicine News(10 mins):